IL-23 Inhibitors
TildrakizumabTildrakizumab-asmn
Tildrakizumab requires dosing every 12 weeks.
This page is general information about a medication and how cash prices for it are set. It is not medical advice and does not replace the label, your prescriber or your pharmacist. How we handle medical information
About Tildrakizumab
Tildrakizumab requires dosing every 12 weeks.
Tildrakizumab selectively inhibits IL-23.
A full cash-pay guide for Tildrakizumab has not been written yet. The facts above come from the medication catalogue; confirm details against the FDA-approved label on DailyMed.
How Script Unlock gets you a cash price for Tildrakizumab
Prices on this site come from pharmacies responding to a real prescription. We do not publish estimated, average or "typical" prices, because none of those would be your price.
- 1You upload your prescription
A photo of your Tildrakizumab prescription is enough. Nothing is sold on the site; you are asking pharmacies to quote.
- 2Licensed pharmacies respond
Pharmacies that Script Unlock has verified see the request and each can reply with its own cash price for your exact drug, strength and quantity.
- 3You choose and pay the pharmacy
You compare the responses, pick a pharmacy, and pay that pharmacy directly when you collect. Script Unlock never takes a patient payment and never sets the price.
Related medications
Script Unlock is a marketplace that lets licensed pharmacies quote a cash price on your prescription. It does not prescribe, dispense or sell medication, does not process patient payments, and does not give medical advice. Always follow the instructions of your prescriber and pharmacist and read the medication guide supplied with your medicine.